Table 1. Clinicopathological information of the three COAD patient cohorts in this study.
Covariates | Type | Total | Testing | Training | P value |
---|---|---|---|---|---|
Age | ≤65 | 183 | 93 | 90 | 0.786 |
>65 | 263 | 129 | 134 | ||
Gender | Female | 212 | 104 | 108 | 0.8459 |
Male | 234 | 118 | 116 | ||
Stage | Stage I–II | 250 | 126 | 124 | 0.7071 |
Stage III–IV | 185 | 89 | 96 | ||
Unknown | 11 | 7 | 4 | ||
T | T1–2 | 86 | 47 | 39 | 0.3878 |
T3–4 | 359 | 175 | 184 | ||
Unknown | 1 | 0 | 1 | ||
M | M0 | 329 | 161 | 168 | 1 |
M1 | 61 | 30 | 31 | ||
Unknown | 56 | 31 | 25 | ||
N | N0 | 265 | 134 | 131 | 0.7585 |
N1–2 | 181 | 88 | 93 |
COAD, colon adenocarcinoma.